Tempest Therapeutics, Inc.
TPST
$0.91
-$0.08-7.93%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 33.37% | -155.03% | 70.89% | 66.74% | 17.76% |
| Total Depreciation and Amortization | -10.45% | -11.76% | 32.65% | -31.96% | -56.77% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 34.76% | 1,108.33% | -47.01% | -79.19% | -18.84% |
| Change in Net Operating Assets | 125.25% | -138.25% | -124.66% | -169.82% | -193.43% |
| Cash from Operations | 67.04% | 5.45% | 64.78% | 33.42% | -53.01% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 100.00% | 100.00% | -- |
| Issuance of Common Stock | -67.70% | 14.83% | -88.51% | -99.65% | 19.11% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 46.08% | 335.23% | -79.02% | -99.16% | -73.67% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 85.81% | 32.60% | -97.53% | 21.83% | -501.58% |